5. The multi-stage valuation model Consider the case of Purple Panda Pharmaceuticals Inc.: Purple Panda Pharmaceuticals Inc. is expected to generate a free cash flow (FCF) of $1,670,000 this year, and the FCF is expected to grow at a rate of 18% over the following two years ( FCF2 and FCF3). After the third year, however, the company's FCFs are expected to grow at a constant rate of 8% per year, which will last forever (FCF 4). If Purple Panda's weighted average cost of capital (WACC) is 16%, complete the following table and compute the current value of Purple Panda's operations. Round all dollar amounts to the nearest whole dollar, and assume that the firm does not have any nonoperating assets in its balance sheet and that all FCFs occur at the end of year. Purple Panda's debt has a market value of $18,378,876, and Purple Panda has no preferred stock in its capital structure. If Purple Panda has 300,000 shares of common stock outstanding, then the total value of the company is , and the estimated intrinsic value per share of its common stock is per share (rounded to the nearest dollar). Assume the following: - The end of Year 3 differentiates Purple Panda's short-term and long-term FCFs. - Professionally-conducted studies have shown that more than 80% of the average company's share price is attributable to long-termrather than short-term-cash flows. Is the percentage of Purple Panda's expected long-term cash flows consistent with the value cited in the professional studies? Yes, because 82.07% of the firm's share price is derived from its expected long-term free cash flows. No, because the percentage of Purple Panda's expected long-term cash flows is actually 17.93%. No, because only 62.76% of the firm's share price is derived from its expected long-term free cash flows. Yes, because 72.22% of the firm's share price is derived from its expected long-term free cash flows